Los Angeles Biotechnology Network
GOOGLE Advertise With Biotech Networks
  • Home
  • About
  • News
    • All LABN News
    • Trending LABN News
  • Jobs
    • All LABN Jobs
    • Post A Job
  • Advertise
  • BN Connect
    • About Biotech Networks Connect
    • BN Connect
  • Subscribe
  • Contact
News Ticker
  • [ November 11, 2026 ] Assistant Research Scientist – Pasadena, CA 91125 Los Angeles Biotech Jobs
  • [ November 11, 2026 ] Jewish Big Brothers Big Sisters of Los Angeles Welcomes Farnaz Golshani as CEO Los Angeles Biotech News
  • [ November 11, 2026 ] LaserAway, Nation’s Largest Aesthetic Dermatology Brand, Opens Its 242nd Clinic Los Angeles Biotech News
  • [ November 11, 2026 ] Skylight and Hearth & Hand™ with Magnolia Bring Joanna Gaines’ Favorite Family Recipes Directly to Skylight Calendar Los Angeles Biotech News
  • [ November 11, 2026 ] Amgen builds Sjögren’s case with detailed phase 3 data ahead of Novartis showdown Los Angeles Biotech News
HomeLos Angeles Biotech NewsInversago Pharma Raises $95 million CAD in Series C Financing

Inversago Pharma Raises $95 million CAD in Series C Financing

October 17, 2022 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on Inversago Pharma Raises $95 million CAD in Series C Financing

MONTREAL–(BUSINESS WIRE)– #AmgenVentures–Inversago Pharma raises $95 million CAD in Series C Financing

Previous

ImaginAb and Cyclotek Enter into Manufacturing and Distribution Agreement for CD8 ImmunoPET Agent in Australia

Next

TIAP and Evotec Expand LAB150 BRIDGE Partnership to Include Amgen

Follow/Subscribe

GOOGLE Advertise With Biotech Networks
POST A JOB
Advertise With Biotech Networks

Copyright © 2026 Biotech Networks, LLC

Get Weekly/Trending/Daily News & Jobs Delivered to Your Inbox